United States

Analyst Research Report Snapshot


Oxford BioMedica Plc






15 Oct 2014





Companies referenced:


Available for Immediate Download

Oxford BioMedica Plc Company Profile is the essential source for top-level company data and information. Oxford BioMedica Plc Company Profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Oxford BioMedica is engaged in developing gene-based medicines and therapeutic vaccines. The company’s technology platform includes the LentiVector gene delivery technology that targets the diseases of the central nervous system and the eyes; and tumor antigen (5T4), a target for anti-cancer therapy. The company operates in the US and the UK. It is headquartered in Oxford, the UK, and employs around 106 people. The company recorded revenues of £5.4 million (approximately $8.4 million) in the fiscal year ended December 2013, a decrease of 30.7% compared to 2012. The company's operating loss was £12.8 million (approximately $20.1 million) in fiscal 2013, as compared to an operating loss of £10.5 million (approximately $16.4million) in 2012. Its net loss was £11.1 million (approximately $17.4 million) in fiscal 2013, as compared to the net loss of £8.7 million (approximately $13.7 million) in 2012. Scope of the Report - Provides all the crucial information on Oxford BioMedica Plc required for business and competitor intelligence needs -Data is supplemented with details on Oxford BioMedica Plc history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Oxford BioMedica Plc Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Understand prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.